The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.
New, specific drugs for a variety of autoimmune diseases are penetrating the market. This leads to changes: numerous new drug manufacturers, many new drugs and new requirements for injection systems. If you want to be one of the players, you have to be flexible and adapt your production concepts accordingly.
In the interview she explains the consequences of digitisation for the healthcare system. Classical systems and processes are breaking up and need to be redefined. But what exactly does digitisation do to us?
Digitisation is an industrial revolution. New technologies are breaking up and changing markets, conventional products and services are being replaced and established systems require rethinking. The health care system, too, is in flux and undergoing fundamental change. Those who react to change and rethink at an early stage will be successful in the future.
